Cat. #151838
Anti-MOZ [127A]
Cat. #: 151838
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 1-2 weeks
Target: Monocytic Leukaemia Zinc Finger Protein, MOZ, MYST3
Class: Monoclonal
Application: IP ; WB ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: David Heery ; Tasneem Ritchie
Institute: University of Oxford
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-MOZ [127A]
- Clone: 127A
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 225 kDa
- Reactivity: Human
- Host: Mouse
- Application: IP ; WB ; IP ; WB
- Description: MOZ fusion proteins block normal differentiation of myeloid progenitors resulting in AML (acute Myloid Leukaemia).Recombinant fragment of human MOZ (172-321aa) produced as a fusion protein in E. coli.
- Immunogen: GST-MOZ (172-321aa) recombinant protein human MOZ
- Isotype: IgG3 kappa
- Recommended controls: HEK293, K562, U937 cells
Target Details
- Target: Monocytic Leukaemia Zinc Finger Protein, MOZ, MYST3
- Molecular weight: 225 kDa
- Tissue cell line specificity: HEK293, K562, U937 cells
- Target background: MOZ fusion proteins block normal differentiation of myeloid progenitors resulting in AML (acute Myloid Leukaemia).Recombinant fragment of human MOZ (172-321aa) produced as a fusion protein in E. coli.
Applications
- Application: IP ; WB ; IP ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -80° C
- Shipping conditions: Shipping at 4° C
References
- Elizabeth Deeves. 2012. PhD thesis. Novel functions of the MOZ double PHD finder domain.
